SAPIENT GOVERNMENT SERVICES, INC.: $10.8M Department of Health and Human Services Contract
Summary
This $10.8M contract to private entity Sapient Government Services for HRSA's BHW90 BMISS operations and maintenance is a routine renewal. No publicly traded company is directly tied, and the impact on the healthcare IT sector is minimal.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.Contract is a routine $10.8M O&M renewal to a private company.
- 2.No publicly traded company directly benefits; no tickers to trade.
- 3.Healthcare IT sector sees minimal impact; focus on larger contracts or legislation.
Market Implications
This contract has no direct market implications for publicly traded companies. Investors should not adjust positions based on this award. The broader healthcare IT sector may see tailwinds from related legislation, but this specific contract is too small and opaque to drive stock moves.
Full Analysis
The Department of Health and Human Services, through the Health Resources and Services Administration, awarded a $10.8M BPA Call to Sapient Government Services, Inc. for FY26 BMISS Operations and Maintenance. BMISS likely refers to a health workforce data system. Sapient Government Services is a private entity, not a publicly traded company or recognized subsidiary of one. Therefore, no direct stock impact can be attributed.
Because the recipient is private, no public company directly benefits from this award. The contract is a routine operations and maintenance renewal, not a new competitive win that would shift market share. The healthcare IT sector may see indirect benefits from sustained federal investment in health data systems, but this specific contract is too small to move any public company.
Several related healthcare bills are in play, including HR6280 (Access to Genetic Counselor Services Act), HR7961 (H-1Bs for Physicians), HR8875 (Improving Home Dialysis Act), and HR8324 (Great American Healthcare Plan). These bills signal broader legislative support for healthcare workforce and technology, but none directly authorize this contract. The contract appears to be a standard renewal under existing appropriations.
No supply chain beneficiaries can be reliably identified without knowing Sapient's subcontractors. Guessing would produce false positives. Historically, similar O&M contracts for federal health IT systems are routine and do not generate significant market movement for public companies unless they are prime contractors.
Given the private recipient and routine nature, this contract has negligible impact on public equities. Investors should monitor larger HRSA IT contracts or legislative catalysts like the Great American Healthcare Plan for more actionable signals.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
H–1Bs for Physicians and the Healthcare Workforce Act
Access to Genetic Counselor Services Act of 2025
Great American Healthcare Plan
Improving Home Dialysis Act of 2026
MERCK SHARP & DOHME LLC: $2.4B Department of Health and Human Services Contract Vehicle
PA DEPARTMENT OF HUMAN SERVICES: $1.0B Department of Health and Human Services Grant
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $1.5B Department of Homeland Security Grant
HUMAN SERVICES, NEW JERSEY DEPARTMENT OF: $16.9B Department of Health and Human Services Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Contract Details
Recipient
SAPIENT GOVERNMENT SERVICES, INC.
Award Amount
$10,798,683
Awarding Agency
Department of Health and Human Services
Sub-Agency
Health Resources and Services Administration
Contract Type
BPA CALL
Related Bills
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →